ORIGINAL RESEARCH
Published on 17 Nov 2025
Two vs three cycles of neoadjuvant immunochemotherapy for resectable non-small-cell lung cancer: a real-world population-based study
doi 10.3389/fimmu.2025.1654830
- 467 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Methods in Cancer Immunity and Immunotherapy: Volume II
Community Series in Methods in Cancer Immunity and Immunotherapy: Volume II
6,891
Total downloads
32k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 30 Oct 2025
Immunotherapy of chimeric antigen receptor NK cells: status and its promising future
doi 10.3389/fimmu.2025.1608277
- 1,412 views
ORIGINAL RESEARCH
Published on 22 Oct 2025
NeoTImmuML: a machine learning-based prediction model for human tumor neoantigen immunogenicity
doi 10.3389/fimmu.2025.1681396
- 1,170 views
ORIGINAL RESEARCH
Published on 16 Oct 2025
Pterostilbene inhibits non-small cell lung cancer progression by activating the STING pathway and enhancing antitumor immune response
doi 10.3389/fimmu.2025.1622284
- 1,541 views
REVIEW
Published on 15 Oct 2025
Significance of circular RNAs in regulating protein ubiquitination for malignant tumor progression
doi 10.3389/fimmu.2025.1610112
- 967 views
REVIEW
Published on 02 Oct 2025
Emerging strategies in colorectal cancer immunotherapy: enhancing efficacy and survival
doi 10.3389/fimmu.2025.1616414
- 1,706 views
ORIGINAL RESEARCH
Published on 01 Sep 2025
Urokinase-type plasminogen activator deficiency enhances CD8+ T cell infiltration and anti-PD-1 therapy efficacy in prostate cancer
doi 10.3389/fimmu.2025.1625226
- 1,428 views
- 1 citation
METHODS
Published on 24 Apr 2025
SAPrIm 2.0: a semi-automated protocol for mid-throughput soluble HLA immunopeptidomics
doi 10.3389/fimmu.2025.1546629
- 2,895 views
ORIGINAL RESEARCH
Published on 12 Mar 2025
Zanubrutinib plus R-CHOP improves the treatment effect of newly diagnosed diffuse large B cell lymphoma with double expression of MYC and BCL-2
doi 10.3389/fimmu.2025.1526318
- 3,828 views
- 1 citation
REVIEW
Published on 25 Feb 2025
Research progress of T cells in cholangiocarcinoma
doi 10.3389/fimmu.2025.1453344
- 2,253 views
- 1 citation
ORIGINAL RESEARCH
Published on 24 Jan 2025
Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors
doi 10.3389/fimmu.2025.1499074
- 2,956 views
- 2 citations
STUDY PROTOCOL
Published on 09 Oct 2024
SHR-8068 combined with adebrelimab and bevacizumab in the treatment of refractory advanced colorectal cancer: study protocol for a single-arm, phase Ib/II study
doi 10.3389/fimmu.2024.1450533
- 2,683 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: